Optimizing TPD-based oncology drug development: the critical role of PDR distribution in POI-positive cancer cells
aSchool of Life Science and Technology, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing 210031, China
bCenter for Translation Medicine Research and Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
cInstitute of Microphysiological Systems, Southeast University, Nanjing 211189, China
* Corresponding authors.
收起